The discussion delves into the complex public perception of e-cigarettes, particularly in light of the mysterious lung disease linked to vaping in 2019. Jamie highlights the distinction between mainstream nicotine products and the more dangerous illicit market. As the FDA reviews applications from e-cigarette makers, the future of these products hangs in the balance, with potential outcomes ranging from continued sales to significant restrictions or even a complete market withdrawal.
